Propofol sedation for flexible bronchoscopy (fb) and endobronchial ultrasound bronchoscopy (ebus): our experience.

We aimed to study the safety of propofol deep sedation managed by interventional pulmonologist in our centreObservational retrospective study of 900FB/EBUS between 2014-16. We collected epidemiological variables, indications, monitoring parameters and diagnostic procedures(DP)Sedation complications: oxygen saturation(SO2)<90% or fall≥6%, systolic blood pressure(SBP)>160mmHg, SBP<90mmHg, heart rate(HR)>120bpm or HR<60bpmStatistical analysis SPSSv22900 procedures analyzed (75%ambulatory, 78%male, average age65±12years). Indications in order were: neoplasms(36%) and mediastinal staging(15%), followed by infections(10%) and hemoptysis(8%)Almost 2000DP were performed including bronchial aspirate(700), brushing(231), bronchoalveolar lavage(81), transbronchial needle aspiration(182), endobronchial and transbronchial biopsy(371) and EBUS(212). The majority of patients underwent 1(32%) or 2(22%)DPPropofol average dose was 276mg(3.9mg/kg), classifying patients into 4groups: <2mg/kg(21%) 2-4mg/kg(38%) 4-6mg/kg(23%) and >6mg/kg(15%)SO2<90% occurred in 15% patients and falls>6%: 15%; SBP>160mmHg: 22%; SBP<90mmHg: 10%; HR>120bpm: 3% and HR<60bpm 22%About complications arising from DP: moderate bleeding happened in 3%, 2 patients suffered stomach expansion and only 1 required intubation and transfer to ICUNo relation was found between complications rate and propofol dose(p=0.4); while hypotension was significantly higher in patients receiving...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Interventional Pulmonology Source Type: research